Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Reilly

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Neuromuscular Disorders : NMD|May 11, 2006
136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The NetherlandsM M Reilly, P de Jonghe, D Pareyson
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1995
Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological studyM M Reilly, H Staunton, A E Harding
QJM : Monthly Journal of the Association of Physicians|August 9, 2001
Refsum's diseaseA J Wills, N J Manning, M M Reilly
Brain Research|January 4, 2020
Are we prepared for clinical trials in Charcot-Marie-Tooth disease?A M Rossor, M E Shy, M M Reilly
Neuromuscular Disorders : NMD|September 21, 2010
168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT)M M Reilly, M E Shy, F Muntoni, et al.
Pharmanutrition|March 26, 2013
Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerationsF Visioli, M M Reilly, M Rimoldi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 15, 2006
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxiaC Douglass, K Suvarna, M M Reilly, et al.
Neuromuscular Disorders : NMD|May 11, 2015
Clinical, neuropathological and radiological evidence for a rare complication of rituximab therapyE G Healy, R Phadke, M Kidd, et al.
Journal of Neurology|October 1, 1995
Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77)M M Reilly, D Adams, M B Davis, et al.
Journal of Neurology|February 22, 2012
Isolated motor conduction block associated with infliximabA W Michell, A Gaitatzis, J Burge, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Neuromuscular Disorders : NMD|May 11, 2006
136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The NetherlandsM M Reilly, P de Jonghe, D Pareyson
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1995
Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological studyM M Reilly, H Staunton, A E Harding
QJM : Monthly Journal of the Association of Physicians|August 9, 2001
Refsum's diseaseA J Wills, N J Manning, M M Reilly
Brain Research|January 4, 2020
Are we prepared for clinical trials in Charcot-Marie-Tooth disease?A M Rossor, M E Shy, M M Reilly
Neuromuscular Disorders : NMD|September 21, 2010
168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT)M M Reilly, M E Shy, F Muntoni, et al.
Pharmanutrition|March 26, 2013
Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerationsF Visioli, M M Reilly, M Rimoldi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 15, 2006
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxiaC Douglass, K Suvarna, M M Reilly, et al.
Neuromuscular Disorders : NMD|May 11, 2015
Clinical, neuropathological and radiological evidence for a rare complication of rituximab therapyE G Healy, R Phadke, M Kidd, et al.
Journal of Neurology|October 1, 1995
Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77)M M Reilly, D Adams, M B Davis, et al.
Journal of Neurology|February 22, 2012
Isolated motor conduction block associated with infliximabA W Michell, A Gaitatzis, J Burge, et al.
Pageof 7